Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 348 participants.

Also called NCT05604638

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 348 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05604638
Other papers using this trial's data
  • Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial JAMA, 2026-06-09 DOI, PubMed 42100960, PMC13156798 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05604638. Randomized; quadruple masking; primary purpose treatment. Start 2024-04-24 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
Acronym
INSTANT
Condition
Acute Ischemic Stroke
Intervention (Drug)
Tirofiban Hydrochloride
Intervention (Drug)
Placebo
Lead sponsor
Second Affiliated Hospital of Guangxi Medical University (class: other)
Collaborator
Ganzhou City People's Hospital (class: other)

Record details

Record id
cardio:ct-nct05604638
Content hash
e84aebbf75a1fbfd216b27e06b7c9e47140d684e985b0541ce81bfc4960dc7b0